Quantitative analysis of interstitial lung abnormalities on computed tomography to predict symptomatic radiation pneumonitis after lung stereotactic body radiotherapy
-
Published:2024-09
Issue:
Volume:198
Page:110408
-
ISSN:0167-8140
-
Container-title:Radiotherapy and Oncology
-
language:en
-
Short-container-title:Radiotherapy and Oncology
Author:
Yoneyama Masahiro,
Matsuo YukinoriORCID,
Kishi NorikoORCID,
Itotani Ryo,
Oguma Tsuyoshi,
Ozasa Hiroaki,
Tanizawa KiminobuORCID,
Handa Tomohiro,
Hirai Toyohiro,
Mizowaki Takashi
Reference47 articles.
1. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403;Nagata;Int J Radiat Oncol Biol Phys,2015
2. Kong F-M (Spring), Moiseenko V, Zhao J, Milano MT, Li L, Rimner A, et al. Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma? Int J Radiat Oncol Biol Phys 2021;110:172–87. 10.1016/j.ijrobp.2018.11.028.
3. Radiation-Induced Lung Injury: Assessment and Management;Hanania;Chest,2019
4. Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies;Zhao;Int J Radiat Oncol Biol Phys,2016
5. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival after Stereotactic Body Radiation Therapy for Lung Cancer;Ueki;J Thorac Oncol,2015